REQUEST A DEMO
Total
USD $0.00
Search more companies

Antex Pharma Private Limited (India)

Main Activities: Basic Chemical Manufacturing
Full name: Antex Pharma Private Limited Profile Updated: January 13, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English Download a sample report

Antex Pharma Private Limited is an unlisted company, incorporated on 06/03/2009. It has its registered office in the State of Delhi, India. Company's corporate identification number (CIN) is U24100DL2009PTC188276 and registration number is 188276. The company is a trade company, it is engaged in wholesale trading.

Legal Address
423, Main Bawana Road Shahbad Daulatpur
North West Delhi; Delhi; Postal Code: 110042

Contact Details: Purchase the Antex Pharma Private Limited report to view the information.

Basic Information
Registered Capital:
Purchase the Antex Pharma Private Limited report to view the information.
Financial Auditors:
Purchase the Antex Pharma Private Limited report to view the information.
Incorporation Date:
March 06, 2009
Key Executives
Purchase this report to view the information.
Promoter Director
Purchase this report to view the information.
Promoter Director
Ownership Details
Purchase this report to view the information.
9.1%
Company Performance
Financial values in the chart are available after Antex Pharma Private Limited report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency INR. Absolute financial data is included in the purchased report.
Net sales revenue
23.27%
Total operating revenue
23.25%
Operating profit (EBIT)
-55.32%
EBITDA
-52.88%
Net Profit (Loss) for the Period
-58.67%
Total Assets
35.42%
Total Equity
13.65%
Operating Profit Margin (ROS)
-1.78%
Net Profit Margin
-1.24%
Return on Equity (ROE)
-14.16%
Debt/Equity
38.18%
Quick Ratio
-0.16%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?